Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2019	Jul. 31, 2018	Jul. 31, 2019	Jul. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			1,233,853
Beginning Balance	$ (697,192)	$ (615,750)	$ (678,551)	$ (595,602)
Net loss	$ (19,632)	(19,258)	$ (38,273)	(39,406)
Ending Balance (in shares)	1,233,853		1,233,853
Ending Balance	$ (716,824)	$ (635,008)	$ (716,824)	$ (635,008)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	81,323	81,323	81,323	81,323
Ending Balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(779,748)	(698,306)	(761,107)	(678,158)
Net loss	(19,632)	(19,258)	(38,273)	(39,406)
Ending Balance	$ (799,380)	$ (717,564)	$ (799,380)	$ (717,564)